7 Citations (Scopus)

Abstract

EPAC proteins are therapeutic targets for the potential treatment of cardiac hypertrophy and cancer metastasis. Several laboratories use a tetrahydroquinoline analog, CE3F4, to dissect the role of EPAC1 in various disease states. Here, we report SAR studies with tetrahydroquinoline analogs that explore various functional groups. The most potent EPAC inhibitor 12a exists as a mixture of inseparable E (major) and Z (minor) rotamers. The rotation about the N-formyl group indeed impacts the activity against EPAC.

Original languageEnglish (US)
Pages (from-to)1183-1187
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume8
Issue number11
DOIs
StatePublished - Nov 9 2017

Fingerprint

Structure-Activity Relationship
Heart Neoplasms
Cardiomegaly
Functional groups
Neoplasm Metastasis
1,2,3,4-tetrahydroquinoline
erythromycin propionate-N-acetylcysteinate
Proteins
Therapeutics

Keywords

  • dynamic NMR
  • exchange protein directly activated by cAMP
  • rotamer
  • tetrahydroquinoline

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Cite this

Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors. / Sonawane, Yogesh A.; Zhu, Yingmin; Garrison, Jered C; Ezell, Edward L.; Zahid, Muhammad; Cheng, Xiaodong; Natarajan, Amarnath.

In: ACS Medicinal Chemistry Letters, Vol. 8, No. 11, 09.11.2017, p. 1183-1187.

Research output: Contribution to journalArticle

@article{a8b3410b8828494e97238c03af1093db,
title = "Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors",
abstract = "EPAC proteins are therapeutic targets for the potential treatment of cardiac hypertrophy and cancer metastasis. Several laboratories use a tetrahydroquinoline analog, CE3F4, to dissect the role of EPAC1 in various disease states. Here, we report SAR studies with tetrahydroquinoline analogs that explore various functional groups. The most potent EPAC inhibitor 12a exists as a mixture of inseparable E (major) and Z (minor) rotamers. The rotation about the N-formyl group indeed impacts the activity against EPAC.",
keywords = "dynamic NMR, exchange protein directly activated by cAMP, rotamer, tetrahydroquinoline",
author = "Sonawane, {Yogesh A.} and Yingmin Zhu and Garrison, {Jered C} and Ezell, {Edward L.} and Muhammad Zahid and Xiaodong Cheng and Amarnath Natarajan",
year = "2017",
month = "11",
day = "9",
doi = "10.1021/acsmedchemlett.7b00358",
language = "English (US)",
volume = "8",
pages = "1183--1187",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors

AU - Sonawane, Yogesh A.

AU - Zhu, Yingmin

AU - Garrison, Jered C

AU - Ezell, Edward L.

AU - Zahid, Muhammad

AU - Cheng, Xiaodong

AU - Natarajan, Amarnath

PY - 2017/11/9

Y1 - 2017/11/9

N2 - EPAC proteins are therapeutic targets for the potential treatment of cardiac hypertrophy and cancer metastasis. Several laboratories use a tetrahydroquinoline analog, CE3F4, to dissect the role of EPAC1 in various disease states. Here, we report SAR studies with tetrahydroquinoline analogs that explore various functional groups. The most potent EPAC inhibitor 12a exists as a mixture of inseparable E (major) and Z (minor) rotamers. The rotation about the N-formyl group indeed impacts the activity against EPAC.

AB - EPAC proteins are therapeutic targets for the potential treatment of cardiac hypertrophy and cancer metastasis. Several laboratories use a tetrahydroquinoline analog, CE3F4, to dissect the role of EPAC1 in various disease states. Here, we report SAR studies with tetrahydroquinoline analogs that explore various functional groups. The most potent EPAC inhibitor 12a exists as a mixture of inseparable E (major) and Z (minor) rotamers. The rotation about the N-formyl group indeed impacts the activity against EPAC.

KW - dynamic NMR

KW - exchange protein directly activated by cAMP

KW - rotamer

KW - tetrahydroquinoline

UR - http://www.scopus.com/inward/record.url?scp=85033407691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033407691&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.7b00358

DO - 10.1021/acsmedchemlett.7b00358

M3 - Article

VL - 8

SP - 1183

EP - 1187

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 11

ER -